188 related articles for article (PubMed ID: 15458437)
21. The role of T-helper lymphocytes in priming for experimental autoimmune glomerulonephritis in the BN rat.
Reynolds J; Sallie BA; Syrganis C; Pusey CD
J Autoimmun; 1993 Oct; 6(5):571-85. PubMed ID: 8240662
[TBL] [Abstract][Full Text] [Related]
22. In vivo treatment with a monoclonal antibody to T helper cells in experimental autoimmune glomerulonephritis in the BN rat.
Reynolds J; Pusey CD
Clin Exp Immunol; 1994 Jan; 95(1):122-7. PubMed ID: 8287595
[TBL] [Abstract][Full Text] [Related]
23. Anti-perforin antibody treatment ameliorates experimental crescentic glomerulonephritis in WKY rats.
Fujinaka H; Yamamoto T; Feng L; Nameta M; Garcia G; Chen S; El-shemi AA; Ohshiro K; Katsuyama K; Yoshida Y; Yaoita E; Wilson CB
Kidney Int; 2007 Oct; 72(7):823-30. PubMed ID: 17622272
[TBL] [Abstract][Full Text] [Related]
24. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.
Bolton WK; Chen L; Hellmark T; Wieslander J; Fox JW
J Am Soc Nephrol; 2005 Sep; 16(9):2657-66. PubMed ID: 16049074
[TBL] [Abstract][Full Text] [Related]
25. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen.
Abbate M; Kalluri R; Corna D; Yamaguchi N; McCluskey RT; Hudson BG; Andres G; Zoja C; Remuzzi G
Kidney Int; 1998 Nov; 54(5):1550-61. PubMed ID: 9844131
[TBL] [Abstract][Full Text] [Related]
26. Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury.
Dean EG; Wilson GR; Li M; Edgtton KL; O'Sullivan KM; Hudson BG; Holdsworth SR; Kitching AR
Kidney Int; 2005 Feb; 67(2):566-75. PubMed ID: 15673304
[TBL] [Abstract][Full Text] [Related]
27. Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury.
Allen AR; McHale J; Smith J; Cook HT; Karkar A; Haskard DO; Lobb RR; Pusey CD
J Immunol; 1999 May; 162(9):5519-27. PubMed ID: 10228033
[TBL] [Abstract][Full Text] [Related]
28. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis.
Nishikawa K; Linsley PS; Collins AB; Stamenkovic I; McCluskey RT; Andres G
Eur J Immunol; 1994 Jun; 24(6):1249-54. PubMed ID: 8206086
[TBL] [Abstract][Full Text] [Related]
29. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
[TBL] [Abstract][Full Text] [Related]
30. Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism.
Wu J; Hicks J; Ou C; Singleton D; Borillo J; Lou YH
J Immunol; 2001 Aug; 167(4):2388-95. PubMed ID: 11490029
[TBL] [Abstract][Full Text] [Related]
31. Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice.
Wakayama H; Hasegawa Y; Kawabe T; Hara T; Matsuo S; Mizuno M; Takai T; Kikutani H; Shimokata K
Eur J Immunol; 2000 Apr; 30(4):1182-90. PubMed ID: 10760808
[TBL] [Abstract][Full Text] [Related]
32. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model.
Aoki-Ota M; Kinoshita M; Ota T; Tsunoda K; Iwasaki T; Tanaka S; Koyasu S; Nishikawa T; Amagai M
J Invest Dermatol; 2006 Jan; 126(1):105-13. PubMed ID: 16417225
[TBL] [Abstract][Full Text] [Related]
33. Resistance of CD28-deficient mice to autologous phase of anti-glomerular basement membrane glomerulonephritis.
Nitta K; Horita S; Ogawa S; Matsumoto M; Hara Y; Okano K; Hayashi T; Abe R; Nihei H
Clin Exp Nephrol; 2003 Jun; 7(2):104-12. PubMed ID: 14586728
[TBL] [Abstract][Full Text] [Related]
34. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.
Takeda S; Takahashi M; Sado Y; Takeuchi K; Hakamata Y; Shimizu H; Kaneko T; Yamamoto H; Ito C; Ookawara S; Asano Y; Kusano E; Kobayashi E
Nephrol Dial Transplant; 2004 Sep; 19(9):2228-36. PubMed ID: 15238626
[TBL] [Abstract][Full Text] [Related]
35. Study of EHS type IV collagen lacking Goodpasture's epitope in glomerulonephritis in rats.
Bolton WK; Luo AM; Fox PL; May WJ; Sturgill BC
Kidney Int; 1995 Feb; 47(2):404-10. PubMed ID: 7536854
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.
Kalluri R; Danoff TM; Okada H; Neilson EG
J Clin Invest; 1997 Nov; 100(9):2263-75. PubMed ID: 9410904
[TBL] [Abstract][Full Text] [Related]
37. T-cell epitope of alpha3 chain of type IV collagen induces severe glomerulonephritis.
Wu J; Borillo J; Glass WF; Hicks J; Ou CN; Lou YH
Kidney Int; 2003 Oct; 64(4):1292-301. PubMed ID: 12969147
[TBL] [Abstract][Full Text] [Related]
38. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
39. Blocking VLA-4 prevents progression of experimental crescentic glomerulonephritis.
Khan SB; Allen AR; Bhangal G; Smith J; Lobb RR; Cook HT; Pusey CD
Nephron Exp Nephrol; 2003; 95(3):e100-10. PubMed ID: 14646362
[TBL] [Abstract][Full Text] [Related]
40. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]